Teleflex
TFX
$248.93
Share price
3.14%
Change (1 day)
-26.66%
Change (1 year)
Categories
Teleflex Incorporated, is an American company providing specialty medical devices for a range of procedures in critical care and surgery.
Revenue for Teleflex (TFX)
Revenue in 2022 (TTM): $2.79 B
According to Teleflex's latest financial reports the company's current revenue (TTM) is $2.79 B. In 2021 the company made a revenue of $2.80 B an increase over the years 2020 revenue that were of $2.53 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Teleflex from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $2.79 B | -0.66% |
| 2021 | $2.80 B | 10.74% |
| 2020 | $2.53 B | -2.24% |
| 2019 | $2.59 B | 6% |
| 2018 | $2.44 B | 14.07% |
| 2017 | $2.14 B | 14.9% |
| 2016 | $1.86 B | 3.22% |
| 2015 | $1.80 B | -1.64% |
| 2014 | $1.83 B | 8.46% |
| 2013 | $1.69 B | 8.86% |
| 2012 | $1.55 B | -0.34% |
| 2011 | $1.56 B | -13.95% |
| 2010 | $1.81 B | -5.82% |
| 2009 | $1.92 B | -20.31% |
| 2008 | $2.42 B | 25.16% |
| 2007 | $1.93 B | -26.92% |
| 2006 | $2.64 B | 5.12% |
| 2005 | $2.51 B | 1.31% |
| 2004 | $2.48 B | 8.89% |
| 2003 | $2.28 B | 9.93% |
| 2002 | $2.07 B | 8.99% |
| 2001 | $1.90 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $94.94 B | 3,301.71% | 🇺🇸 USA |
 Abiomed ABMD | $1.07 B | -61.52% | 🇺🇸 USA |
 Becton Dickinson BDX | $18.99 B | 580.71% | 🇺🇸 USA |
 Boston Scientific BSX | $12.68 B | 354.38% | 🇺🇸 USA |
 General Electric GE | $76.55 B | 2,642.88% | 🇺🇸 USA |
 Cooper Companies COO | $3.37 B | 21.09% | 🇺🇸 USA |
 Merit Medical MMSI | $1.15 B | -58.76% | 🇺🇸 USA |
 AngioDynamics ANGO | $0.32 B | -88.25% | 🇺🇸 USA |
 Integra LifeSciences IART | $1.55 B | -44.19% | 🇺🇸 USA |